Compugen | CGEN - Capitaux Propres Et Réserves





Capitaux Propres Et Réserves Changement Date
Arca Biopharma USD 486.79M 143.15M 2025-09
aTyr Pharma USD 80.24M 5.58M 2025-09
Bio Path USD -7.16M 4.57M 2025-06
Brainstorm Cell Therapeutics USD -7.69M 1.64M 2025-09
Cara Therapeutics USD 32.93M 41M 2025-06
Clal Biotechnology ILS 121.41M 4.62M 2023-12
Compugen USD 43.83M 6.43M 2025-09
Immunic USD 10.5M 23.41M 2025-09
Infinity Pharmaceuticals USD -37.41M 9.08M 2023-06
Minerva Neurosciences USD -140.75M 106.17M 2025-12
RedHill Biopharma USD -4.41M 271K 2025-06
TherapeuticsMD USD 27.67M 990K 2024-06